[Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].
Estrada
P N
PN
Servicios de Nefrología, Hospital Universitario La Paz, 28046 Madrid.
Bajo
M A
MA
del Peso
G
G
Iglesias
P
P
Díez
J J
JJ
Fernández-Reyes
M J
MJ
Grande
C
C
Sánchez Hernández
R
R
Selgas
R
R
D052242:Adiponectin / Q000097:blood / Q000172:deficiency / Q000235:genetics; D000818:Animals; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D023903:Coronary Restenosis / Q000097:blood / Q000453:epidemiology / Q000209:etiology; D004195:Disease Models, Animal; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D007333:Insulin Resistance; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D047495:PPAR gamma / Q000819:agonists; D010530:Peritoneal Dialysis; D011446:Prospective Studies; D011758:Pyrroles / Q000627:therapeutic use; D051381:Rats; D006435:Renal Dialysis; D012307:Risk Factors; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use; D014511:Uremia / Q000097:blood* / Q000150:complications
C499918:ADIPOQ protein, human; D052242:Adiponectin; C499920:Adipoq protein, rat; D006538:Heptanoic Acids; D047495:PPAR gamma; D011758:Pyrroles; D045162:Thiazolidinediones; D000069059:Atorvastatin